OGT's Protein Array at Heart of Sengenics Deal, Test-Development Programs | GenomeWeb

Oxford Gene Technology, a UK firm perhaps better known for its menu of chromosomal microarrays and foundational array IP, has seen its protein array platform emerge from the shadows in recent weeks after signing an agreement that gives its main partner in Asia the ability to offer the arrays directly.

In addition, OGT recently provided an update on tests that have been developed, in part, using the platform, such as an assay for systemic lupus erythematosus.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PNAS this week: diatom genetic diversity, microfluidic droplet method for single-cell screening, and more.

Scientific publishers are looking into whether artificial intelligence can help the peer-review process, Wired reports.

Researchers are using gene editing to develop more robust livestock and crops, AFP reports.

Researchers rally near the American Association for the Advancement of Science annual meeting in Boston.